These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 24395852)
1. Impact of cancer research bureaucracy on innovation, costs, and patient care. Steensma DP; Kantarjian HM J Clin Oncol; 2014 Feb; 32(5):376-8. PubMed ID: 24395852 [No Abstract] [Full Text] [Related]
2. Proposed US Government budget cuts would 'devastate' cancer research. Furlow B Lancet Oncol; 2017 May; 18(5):577. PubMed ID: 28343979 [No Abstract] [Full Text] [Related]
3. Budget cuts in the USA: a short-term win? Lancet Oncol; 2012 Jan; 13(1):1. PubMed ID: 22225713 [No Abstract] [Full Text] [Related]
4. Cancer services insulated from Irish austerity. Holmes D Lancet Oncol; 2012 Jan; 13(1):17. PubMed ID: 22332243 [No Abstract] [Full Text] [Related]
5. American Society of Clinical Oncology: Policy for relationships with companies. American Society of Clinical Oncology J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118 [No Abstract] [Full Text] [Related]
6. StatBite: Key findings from the "Impact on clinical research of European legislation" report. J Natl Cancer Inst; 2010 Mar; 102(5):293. PubMed ID: 20173122 [No Abstract] [Full Text] [Related]
7. Cancer groundshot: going global before going to the moon. Gyawali B; Sullivan R; Booth CM Lancet Oncol; 2018 Mar; 19(3):288-290. PubMed ID: 29508746 [No Abstract] [Full Text] [Related]
8. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123 [No Abstract] [Full Text] [Related]
10. [The recent decision of the German Federal Social Court regarding funding of studies: will oncological studies in Germany be terminated for financial reasons?]. Jacobs VR Onkologie; 2004 Dec; 27(6):589-90. PubMed ID: 15603059 [No Abstract] [Full Text] [Related]
11. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues. Freeman RA J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112 [No Abstract] [Full Text] [Related]
12. US clinical-research system in need of review. Ammann AJ Nature; 2013 Jun; 498(7452):7. PubMed ID: 23739388 [No Abstract] [Full Text] [Related]
13. Private Funding for Pancreatic Cancer Research: More Than a Chip Shot. Hendifar AE; Davies L; Tuli R Gastroenterology; 2017 Apr; 152(5):918-921.e2. PubMed ID: 28259790 [No Abstract] [Full Text] [Related]
14. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme. Jordan KA Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696 [No Abstract] [Full Text] [Related]
15. [Clinical trials contracts: quality assurance of the sub-contractor is the orderer's responsibility]. Karlmark B Lakartidningen; 2008 Mar 18-Apr 1; 105(12-13):928; author reply 928. PubMed ID: 18461867 [No Abstract] [Full Text] [Related]
16. Make clinical research top priority. Prophet S J AHIMA; 2002 Jan; 73(1):19-20. PubMed ID: 12469657 [No Abstract] [Full Text] [Related]
17. A Call for Value in Cancer Research. Gross CP; Emanuel EJ JAMA Oncol; 2016 Jan; 2(1):11-2. PubMed ID: 26447464 [No Abstract] [Full Text] [Related]
18. Shooting for the moon, and the stars? The Lancet Oncology Lancet Oncol; 2016 Aug; 17(8):1019. PubMed ID: 27511144 [No Abstract] [Full Text] [Related]
19. Improving the protocol implementation process: the National Cancer Institute's response. Abrams JS; Mooney M; Zwiebel J; Friedman S J Clin Oncol; 2014 Aug; 32(23):2515-6. PubMed ID: 25002734 [No Abstract] [Full Text] [Related]